Internal Medicine · Guaynabo, PR
NPI
1639124977
Since 2006
Specialty
Internal Medicine
Code 225B00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Maramar Plaza 1250, 101 San Patricio Avenue
Guaynabo, PR, 00968
Phone (787) 200-4545
Medicare paid, 2024
$83K
2,002 services
Medicare patients, 2024
237
Average age 77
Drug cost, 2024
$2.7M
13,671 prescriptions
Company payments, 2025
$14.21
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ppluis Echegaray was code 99214 (office e&m - established), 515 times for 214 patients. In total Ppluis Echegaray billed 2,002 services in 12 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 515 | 214 | $83.59 | $43K |
| 94375 Pulmonary Function Testing | Office | 460 | 227 | $26.10 | $12K |
| 94200 Pulmonary Function Testing | Office | 459 | 226 | $10.00 | $4,591 |
| 94729 Pulmonary Function Testing | Office | 184 | 184 | $41.00 | $7,545 |
| 94727 Pulmonary Function Testing | Office | 183 | 183 | $31.12 | $5,695 |
| G0008 Administration of influenza virus vaccine | Office | 70 | 70 | $31.99 | $2,239 |
| 90656 Vaccine Product | Office | 70 | 70 | $21.90 | $1,533 |
| 99204 Office E&M - New | Office | 43 | 43 | $111.54 | $4,796 |
By year: 2022 $93K for 2,223 services; 2023 $96K for 2,335 services; 2024 $83K for 2,002 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ppluis Echegaray prescribed most often to Medicare patients was Montelukast Sodium, with 4,558 prescriptions and refills. In total Ppluis Echegaray wrote 13,671 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 4,558 | 6,036 | 1,218 | $48K |
| Prednisone Generic | 1,661 | 1,661 | 982 | $8,817 |
| Fluticasone Propionate Generic | 1,035 | 1,382 | 409 | $18K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 999 | 1,018 | 395 | $39K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 921 | 1,009 | 322 | $224K |
| Symbicort Budesonide/Formoterol Fumarate | 732 | 745 | 274 | $176K |
| Breo Ellipta Fluticasone/Vilanterol | 727 | 759 | 193 | $303K |
| Spiriva Respimat Tiotropium Bromide | 604 | 624 | 168 | $327K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 302 | 309 | 121 | $46K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 236 | 240 | 55 | $157K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 231 | 235 | 45 | $113K |
| Levofloxacin Generic | 153 | 153 | 142 | $1,526 |
| Azithromycin Generic | 147 | 147 | 137 | $1,792 |
| Doxycycline Hyclate Generic | 107 | 107 | 100 | $1,290 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 102 | 103 | 34 | $6,138 |
Brand drugs: - claims; generic drugs: 9,189 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ppluis Echegaray $14.21 ($14.21 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $14.21.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $14.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.